Literature DB >> 19574172

Effects of calcium supplement therapy in women with premenstrual syndrome.

Zinat Ghanbari1, Fedieh Haghollahi, Mamak Shariat, Abbas Rahimi Foroshani, Maryam Ashrafi.   

Abstract

OBJECTIVE: Scientific evidence suggests that cyclic fluctuations in a variety of nutrients, especially calcium, may help to explain some features of premenstrual syndrome (PMS). We determined the efficacy of calcium supplementation in women suffering from PMS.
MATERIALS AND METHODS: A double-blind clinical trial was designed to evaluate the effect of calcium supplement therapy on PMS symptoms. The study groups were selected from young female college students, based on PMS criteria. The subjects were divided in two groups; one group received placebo and the other received 500 mg of calcium carbonate twice daily for 3 months. The severity and intensity of symptoms, including early fatigability, changes in appetite, and depression, were evaluated using a standard questionnaire. Symptoms were compared before and after treatment.
RESULTS: The mean age was 21.4 +/- 3.6 years. Early tiredness, appetite changes, and depressive symptoms were significantly improved in the group receiving calcium treatment compared with the placebo group.
CONCLUSION: Our results showed that calcium supplements reduced early fatigability, changes in appetite, and depression in women with PMS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19574172     DOI: 10.1016/S1028-4559(09)60271-0

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  12 in total

1.  Pneumothorax after acupuncture.

Authors:  Felicity Huisma; Gerald Konrad; Shawn Thomas
Journal:  Can Fam Physician       Date:  2015-12       Impact factor: 3.275

2.  Sexually Transmitted Pathogens, Depression, and Other Manifestations Associated with Premenstrual Syndrome.

Authors:  Caroline Doyle; Walker A Swain; Holly A Swain Ewald; Christine L Cook; Paul W Ewald
Journal:  Hum Nat       Date:  2015-09

Review 3.  Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.

Authors:  Andrea J Rapkin; Judith A Mikacich
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

4.  Association between Depressive Symptoms and Supplemental intake of Calcium and Vitamin D in Older Adults.

Authors:  M N Wu; F He; Q R Tang; J Chen; X Gu; Y J Zhai; F D Li; T Zhang; X Y Wang; J F Lin
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

5.  The effect of wheat germ extract on premenstrual syndrome symptoms.

Authors:  Maryam Ataollahi; Sedigheh Amir Ali Akbari; Faraz Mojab; Hamid Alavi Majd
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

6.  Effects of wheat germ extract on the severity and systemic symptoms of primary dysmenorrhea: a randomized controlled clinical trial.

Authors:  Maryam Atallahi; Sedigheh Amir Ali Akbari; Faraz Mojab; Hamid Alavi Majd
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

7.  Effect of Combined Use of Calcium and Vitamin B6 on Premenstrual Syndrome Symptoms: a Randomized Clinical Trial.

Authors:  Seyedeh Zahra Masoumi; Maryam Ataollahi; Khodayar Oshvandi
Journal:  J Caring Sci       Date:  2016-03-01

8.  Low dietary calcium is associated with self-rated depression in middle-aged Korean women.

Authors:  Yun-Jung Bae; Soon-Kyung Kim
Journal:  Nutr Res Pract       Date:  2012-12-31       Impact factor: 1.926

9.  The Association between the Risk of Premenstrual Syndrome and Vitamin D, Calcium, and Magnesium Status among University Students: A Case Control Study.

Authors:  Afsaneh Saeedian Kia; Reza Amani; Bahman Cheraghian
Journal:  Health Promot Perspect       Date:  2015-10-25

10.  Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study.

Authors:  Elizabeth R Bertone-Johnson; Susan E Hankinson; Nancy G Forger; Sally I Powers; Walter C Willett; Susan R Johnson; JoAnn E Manson
Journal:  BMC Womens Health       Date:  2014-04-12       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.